Everolimus functions and effects

Everolimusis used to treat advanced renal cell carcinoma (RCCcancer that begins in the kidney)that has been unsuccessfully treated with other drugs. Everolimus is also used to treat a certain type of advanced breast cancer that has been treated with at least one other drug. Everolimus is also used to treat certain types of cancer of the pancreas, stomach, bowel, or lungs that have spread or progressed and cannot be treated with surgery. Everolimus is also used to treat tuberous sclerosis (TSC), a genetic disease that causes tumors to grow in many organs. Everolimus is also used to treat subependymal giant cell astrocytoma (SEGA; a type of brain tumor) in adults and children 1 year and older who have TSC. Everolimus (everolimus) is also used with other drugs to treat certain types of seizures in adults and children 2 years of age and older who have TSC. Everolimus is used with other drugs to prevent transplant rejection (an attack of the transplanted organ by the recipient's immune system) in certain adults who have received a kidney transplant.

Everolimus is a kinase inhibitor drug. Everolimus treats cancer by preventing cancer cell replication and reducing the blood supply to cancer cells. Everolimus prevents transplant rejection by reducing the activity of the immune system. Overall survival: The median follow-up times for the overall population and everolimus-treated population were 47.9 months (0-98.7) and 61.4 months (2.1-98.7), respectively. The median OS in the overall population was 46.8 months (95% confidence interval 45.5–47.9). Generally speaking, it is objective. There are officially listed generic drugs in India, IndiaGlenmarkPharmaceutical retail price5mg10tablets900yuan, 10mg10tablets1500yuan. IndiaciplaPharmaceutical retail price5mg10tablets860yuan, 10mg10tablets1300yuan. If you want to get more high-quality information, you can contact YaDE. YaDE will do its best to learn more about high-quality overseas drugs for you.